951. UPLC/MS determination of AB-FUBINACA, AB-CHMINACA and MDMB-CHMICA metabolites in urine samples. (16th September 2016) Authors: Brajković, G.S.; Stošić, J. Jović; Đorđević, S.; Kilibarda, V.; Brajković, Z.Z.; Rančić, D.; Bugarski, I.; Vučinić, S. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
952. Use of a human (non-3D equivalent) skin assay for the detection of adverse reactions and potency. (16th September 2016) Authors: Ahmed, S.S.; Wang, X.N.; Dickinson, A.M. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
953. Use of Computational Fluid Dynamics for optimization of cell-based in vitro methods in inhalation research. (16th September 2016) Authors: Brodbeck, C.; Wolf, K.; Ritter, D.; Knebel, J. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
954. Use of ECVAM validated EpiDerm skin corrosion test (EpiDerm SCT) for sub-categorization according to the UN GHS. (16th September 2016) Authors: Letasiova, S.; Kandarova, H.; Hayden, P.; Klausner, M. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
955. Use of novel kidney safety biomarkers RPA-1 and clusterin as a selection tool for GPCR-agonists. (16th September 2016) Authors: Kissner, T.; Krupp, E.; Gury, T.; Bube, A.; Bartels, T.; Slaoui, M.; Gautier, J.C. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
956. Use of toxicokinetic data in bioaccumulation assessment. (16th September 2016) Authors: Thies, J. Peltola; Lantto, T.A.; Lapenna, S.; Muller, G.; Kloslova, Z.; Caley, J.; Andersen, S.; Gudbrandsen, M.; Hofer, T.; Myhre, O.; Verbruggen, E.; Lepper, P. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
957. Using EOGRTS under REACH, BPD and CLP. (16th September 2016) Authors: Huuskonen, Hannele Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
958. Using knowledge from proprietary data to support ICH M7 regulatory submissions. (16th September 2016) Authors: Myatt, G.J.; Cross, K.; Hasselgren, C.; Quigley, D. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
959. Using large animal models and clinical research to understand organophosphorus toxicity and treatment. (16th September 2016) Authors: Eddleston, Michael Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
960. Using mechanistic information in application of an Adverse Outcome Pathway (AOP) concept for developmental neurotoxicity evaluation. (16th September 2016) Authors: Price, Anna Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗